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In two recent reports in Science, 
James Chen and colleagues provide 
compelling evidence that detection of 
cytosolic DNA triggers the production 
of a novel second messenger, cyclic 
GMP-AMP (cGAMP), which in turn 
activates a signaling pathway that 
induces type I interferons (IFNs) in 
a STING-dependent manner. They 
further unravel a key role for a so 
far uncharacterized murine pro-
tein E330016A19 (human homolog: 
C6ORF150), now termed cGAMP 
synthetase (cGAS), to act as the DNA 
sensor that generates cGAMP.
Innate immune detection of nucleic 
acids is a central component of the 
host response to infection with a wide 
range of pathogens. Pattern recognition 
receptors (PRRs) of distinct subcellular 
localization and differential cellular dis-
tribution provide sensing platforms for 
recognition of foreign DNA and RNA, 
respectively. Accumulation of cytosolic 
DNA activates a host response, which 
is characterized by AIM2-dependent 
secretion of IL-1β and STING-mediated 
activation of the TBK1-IRF3 axis to 
induce antiviral gene expression [1]. 
AIM2 directly interacts with dsDNA, 
thereby leading to the assembly of an 
inflammasome complex that culminates 
in caspase-1 activation and subsequent 
maturation of pro-IL-1β. STING, how-
ever, lacks an obvious DNA-binding 
domain and thus it was reasoned that an 
additional factor(s) would act upstream 
of STING linking DNA binding to acti-
vation of downstream signaling. Up to 
now, a number of candidate DNA recep-
tors have been proposed, including DAI, 
IFI16, LRRFIP1, Ku70, DDX41 and 
DNA-PK, yet except for DNA-PK, their 
in vivo relevance remains uncertain [1, 
2]. Intriguingly, besides its requirement 
for cytosolic DNA sensing, STING was 
also shown to mediate the intracellular 
response towards bacterial-derived cy-
clic di-nucleotides by directly interact-
ing with cyclic di-GMP/AMP [3]. This 
latter finding was further confirmed 
by several independent groups solving 
the crystal structure of cyclic di-GMP 
bound to STING. Given its unequivo-
cal function as a receptor for cyclic 
di-nucleotides, the concept of STING 
serving as an adaptor molecule at the 
same time was challenging. As such, 
the novel work from the Chen lab [4, 
5], introducing cGAS and its product 
cGAMP in cytosolic DNA recogni-
tion, marks an important breakthrough 
in innate immunity, reconciling the 
above-mentioned, seemingly disparate 
functions of STING.   
To study cellular events upstream 
of STING following DNA challenge, 
Wu et al. [5] first established an in 
vitro complementation assay. Cellular 
extracts from STING-silenced, DNA-
stimulated L929 cells were transferred 
to permeabilized THP1 cells, wherein 
activation of IRF3 dimerization was 
monitored. Using this approach the 
investigators demonstrated that a 
transferable, IRF3 activating factor was 
generated upon DNA stimulation and 
that multiple DNA species were able 
to induce this factor. Surprisingly, this 
transferable factor was neither a protein 
nor a nucleic acid, yet STING was re-
quired in the recipient cells to respond to 
this factor. Consistent with the cell type 
specificity for DNA-induced signaling, 
only cells that are known to respond to 
cytosolic DNA were able to induce this 
factor. Performing mass spectrometry 
of STING-bound molecules led to the 
identification of cGAMP as the critical 
factor. Indeed, chemically synthesized 
cGAMP turned out to be a potent 
inducer of IRF3 phosphorylation and 
subsequent type I IFN induction. In 
addition, the critical role for STING in 
cGAMP sensing was proven in gain- 
and loss-of-function studies in cellulo 
and direct binding of cGAMP to STING 
was demonstrated in vitro. With regards 
to the physiological relevance of this 
finding, the authors further showed that 
both HSV-1 and vaccinia virus (VACV) 
induce cGAMP in human and murine 
cells. Altogether, these studies nicely 
demonstrated that certain cell types 
synthesize cGAMP upon cytosolic DNA 
delivery to activate STING.
But what protein is responsible for 
cGAMP synthesis in eukaryotic cells? 
Chen and colleagues addressed this 
question as well, with an intriguing 
result. Cellular extracts from DNA-
responsive L929 cells were collected 
and tested for their ability to produce 
cGAMP. Different purification routes 
yielded three proteins that copuri-
fied in active fractions. Among them, 
E330016A19 turned out to be the most 
promising candidate, given the pres-
ence of a conserved domain found in 
nucleotidyltransferases. In addition, 
the human homolog of E330016A19, 
C6ORF150, was recently characterized 
as an interferon-inducible gene, whose 
overexpression inhibited replication of 
several distinct classes of viruses [6]. In 
fact, overexpression of murine cGAS 
(cGAMP synthetase = E330016A19) 
in the presence of STING led to potent 
type I IFN induction. Moreover, overex-
pression of cGAS in cells or incubation 
of cGAS with nucleotides and DNA 
in vitro was sufficient for the genera-
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tion of cGAMP, whereas distinct point 
mutations within the putative catalytic 
domain of cGAS abrogated the activ-
ity of cGAS. The authors found that 
knocking down cGAS in either human 
or mouse cells compromised the activity 
of cells to respond to DNA or DNA vi-
ruses like HSV-1 or VACV, confirming 
a prominent role of cGAS in DNA sens-
ing. Further studies revealed that cGAS 
was able to bind DNA directly and that 
this activity was dependent on the N-
terminal portion of the protein. Finally, 
the investigation of cGAS localization 
indicated that cGAS was predominantly 
localized in the cytoplasm, and that it 
could form distinctive aggregates co-
localizing with transfected DNA.
Altogether, these two studies provide 
compelling evidence that cGAS directly 
senses the presence of cytosolic DNA to 
produce cGAMP, which in turn activates 
STING to induce antiviral immunity 
(Figure 1).
After all, should this be the end of 
our search for the cytosolic DNA sen-
sor? It seems so. At least the concept 
provided by Chen and colleagues leaves 
only little room for additional cytosolic 
DNA sensing mechanisms that could 
complement the cGAS system. Of 
course, a knockout cell line or animal 
will be required to provide the final 
proof of its non-redundant function in 
DNA sensing. Nevertheless, it is pos-
sible that additional factors contribute 
to or modulate the cGAS-STING axis 
in type I IFN induction, which still 
leaves some space for the previously re-
ported STING-dependent DNA sensing 
mechanisms, such as DDX41 or IFI16 
[7, 8]. Yet again, knockout studies are 
necessary to solve the contribution of 
these factors.
It is interesting to note that cGAS-de-
pendent DNA sensing operates through 
the detour of a second messenger signal-
ing system as opposed to a “convention-
al” protein-protein interaction-based 
signaling cascade, as it is often found in 
PRR signaling. Second messenger sys-
tems are known to greatly amplify the 
strength of a signal, furthermore, they 
usually induce pleiotropic effects, as 
many downstream targets are affected. 
Moreover, the same second messenger 
is often employed by different upstream 
receptors, even though specificity can 
be achieved by spatiotemporal regula-
tion. cGAMP, however, appears to be a 
unique and highly specific second mes-
senger, which poses the question of its 
origin in evolution and its possible func-
tion prior to serving as a cell intrinsic 
STING ligand within the innate immune 
system. In this context, it is tempting to 
speculate that cGAMP exerts additional 
effects, independent of its activity as a 
STING ligand.
Finally it will be interesting to study 
the role of cGAS in antimicrobial im-
munity and sterile inflammation in 
vivo. Conditions, in which cytosolic 
DNA sensing has already been linked to 
STING activation, will be top on the list. 
As such, disease models with specific 
deficiencies in DNA degrading enzymes 
(e.g., TREX1 and DNase II alpha) and 
a documented role of STING-driven 
sterile inflammation will be of great 
interest [9, 10]. Assuming that cGAS 
is required for DNA-dependent inflam-
mation under these conditions, targeting 
cGAS synthetase activity or the binding 
of its product cGAMP to STING using 
a small molecule inhibitor could open 
new avenues in anti-inflammatory 
therapy. In this context, determining the 
crystal structure of cGAS, especially its 
catalytic domain, will be of great value.
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Figure 1 During infection, microbial DNA gains access to the cell cytoplasm and 
binds to cGAS. This interaction activates cGAS to synthesize the second messen-
ger cGAMP, which in turn is recognized by ER-localized STING. This event leads 
to translocation of STING to perinuclear endosomes and recruitment of the kinase 
TBK1. Finally, this series of events induces the transcriptional upregulation of IFN-β 
and additional interferon-stimulated genes. It remains to be determined whether this 
pathway also accounts for accidental recognition of self-DNA in autoimmune and 
autoinflammatory conditions.
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